US FDA Looks To Proactively Update Old Generic Drug Labels Under Pilot
Executive Summary
Concept mentioned during Gottlieb’s 'star' turn at Davos may sound similar to now-withdrawn generic labeling rule, but actually appears based on a proposal from the Friends of Cancer Research to get current clinical guidelines reflected on labels.
You may also be interested in...
Generic Labeling Rule Dies In Latest Reg Agenda, But Electronic Labeling Is Reborn
US FDA also indicated plans to update definition of biologic product and propose a one-page Patient Medication Information in the latest Unified Agenda.
Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling
US FDA wants to work with practitioners to develop suggested prescribing standards, which could then be used to create packaging requirements.
Labeling Updates For Old Drugs Could Be Faster Under Streamlining Proposal
Stakeholder group's proposed pilot program to correct outdated drug labeling calls for US FDA to identify older products needing updates and contract out for evidence reviews, but agency and generic drug industry raise concerns about complexity, resources and product liability.